-
Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
15 Sep 2025 17:00 GMT
… .4
TAK-079 (mezagitamab): Takeda (Millennium Pharmaceuticals)
11.5
PF-06835375: Pfizer … , GC Pharma, UCB Biopharma, Takeda (Millennium Pharmaceuticals), Pfizer, Genosco and Oscotec, Vertex …
-
In ‘biotech winter,’ Boston startups, jobs, and science are being swept away
15 Sep 2025 10:15 GMT
… Dunsire, the former CEO of Millennium Pharmaceuticals who has spent more than …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Essential Thrombocythemia: Likelihood of Approval
27 Oct 2023 16:35 GMT
… the below form
By GlobalData
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Ixazomib citrate by Millennium Pharmaceuticals for Lymphoblastic Lymphoma: Likelihood of Approval
27 Oct 2023 16:35 GMT
… and graft versus host disease.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals (Takeda Oncology), a subsidiary …
-
Pevonedistat hydrochloride by Millennium Pharmaceuticals for Solid Tumor: Likelihood of Approval
10 Feb 2023 09:11 GMT
… is under clinical development by Millennium Pharmaceuticals and currently in Phase I … refractory acute lymphocytic leukemia.
Millennium Pharmaceuticals overview
Millennium Pharmaceuticals is a biopharmaceutical company that …
-
Merkel Cell Carcinoma Market Set For Rapid Growth In The Coming 10 Years Across The 7MM Delveinsight
20 Aug 2025 17:29 GMT
… , including Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals Inc., Novartis, Exelixis, Bristol-Myers …
-
Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight
20 Aug 2025 17:00 GMT
… , including Incyte Corporation, Merck, Pfizer, Millennium Pharmaceuticals Inc., Novartis, Exelixis, Bristol-Myers …
-
Advanced Endometrial Cancer Pipeline Outlook Report 2025: Key 25+ Companies And Breakthrough Therapies Shaping The Future Landscape
13 Aug 2025 00:34 GMT
… Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, … Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, … Five Prime Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Novartis Oncology, …
-
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
04 Aug 2025 12:03 GMT
… President of Corporate Development at Millennium Pharmaceuticals, Inc., from 1999 to 2008 …
-
Advanced Merkel Cell Carcinoma Pipeline Outlook Report 2025: Key 20+ Companies And Breakthrough Therapies Shaping The Future Landscape
30 Jul 2025 03:46 GMT
… , Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol- … , Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol- … Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol-Myers …
About
© 1995-2025